Enlightenment Research, LLC Abb Vie Inc. Transaction History

Enlightenment Research, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$137.62 - $174.96 $396,207 - $503,709	-2,879 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $379,970 - $471,436	2,879 New	2,879 $467,000
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $393,680 - $446,886	-3,700 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $389,277 - $433,677	3,700 New	3,700 $417,000
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $243,036 - $368,472	-3,768 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $271,785 - $340,062	3,768 New	3,768 $334,000
Q3 2019 Oct 16, 2019	SELL	$62.98 - $75.72 $535,330 - $643,620	-8,500 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $558,450 - $713,830	8,500 New	8,500 $675,000

3,695

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.